Clinical Trials Browser

Adenocarcinoma, Stomach Neoplasms

NCT01845337 2023-05-12

TOFFEE

Phase 2 Completed

59 enrolled

Gastrointestinal

Bile Duct Neoplasms, Gastrointestinal Neoplasms, Neoplasms, Unknown Primary, Pancreatic Neoplasms

NCT02191566 2022-12-08

SOHUG

Phase 2 Terminated

8 enrolled

Gastrointestinal

Stomach Neoplasms

NCT05346874 2022-05-26

Neoadjuvant TACiE in Locally Advanced Gastric Cancer

Phase 2 Unknown

37 enrolled

Gastrointestinal

Stomach Neoplasms

NCT03904225 2021-06-23

Tegio Consolidation Therapy for NPC Patients With High Risk of Metastasis

Phase 2 Unknown

220 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT02128243 2021-03-26

MATEO

Phase 2 Completed

242 enrolled

Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Neoplasms, Neoplasm Metastasis, Stomach Neoplasms

NCT04377048 2020-05-06

Nivolumab Adding on Gemcitabine/S-1 in Metastatic Pancreatic Cancer

Phase 2 Unknown

38 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT02216149 2018-08-28

FluoHeart

Phase 2 Terminated

20 enrolled

Gastrointestinal

Colonic Neoplasms, Esophageal Neoplasms, Gastrointestinal Neoplasms, Rectal Neoplasms, Stomach Neoplasms

NCT01608646 2012-05-31

Study of DPD for Predicting Efficacy and Safety to S-1 Plus Oxaliplatin in Gastrointestinal Cancer

Phase 2 Unknown

200 enrolled

Gastrointestinal

Gastrointestinal Neoplasms

Clinical Trials

NeoRacing

TOFFEE

SOHUG

Neoadjuvant TACiE in Locally Advanced Gastric Cancer

Tegio Consolidation Therapy for NPC Patients With High Risk of Metastasis

MATEO

Nivolumab Adding on Gemcitabine/S-1 in Metastatic Pancreatic Cancer

FluoHeart

Study of DPD for Predicting Efficacy and Safety to S-1 Plus Oxaliplatin in Gastrointestinal Cancer